The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.

Educational reference only. Nothing on this page constitutes medical advice or encourages personal use of this compound. Always consult a qualified healthcare provider before any decision involving your health.

Lipo-B (MIC B-12)

MIC B-12 · lipotropic B12 · methyl donor · Inositol (I): a cyclohexa

C
Animal replicated
RouteInjectableGray-market only
C
Evidence grade: Animal replicated

Effect demonstrated in multiple animal studies; human data sparse or extrapolated. Grades summarize evidence quality, not whether a compound is appropriate, legal, or risk-free.

At a glance
What it is
Methionine + Inositol + Choline + Cyanocobalamin/Methylcobalamin — Compounded Lipotropic Injection — Lipotropic Injection Blend, Vitamin/Amino Acid Blend, Metabolic Support.
Why people use it
Used primarily for weight loss and mitochondrial health.
If you only read one thing

Lipo-B / MIC B-12 is the most commercially prominent injectable in the weight loss clinic industry, offered at thousands of medspas and weight loss practices. Each component has legitimate physiological roles in fat metabolism, liver health, and energy production. Inositol has genuine Grade B evidence for insulin resistance in PCOS. Choline is an essential nutrient for hepatic fat export. Methionine is a critical methyl donor for methylation pathways. B12 supports energy metabolism. But the combination, as an injectable weight loss intervention, has never been tested in a randomized controlled trial. The injection route provides no meaningful bioavailability advantage over oral supplementation for methionine, inositol, or choline. The B12 injection advantage is real only in deficient patients. The commercial success of Lipo-B rests on mechanistic plausibility, the psychological effect of receiving an injection, and the generally benign safety profile of the components — not on RCT evidence of the combination's efficacy as a weight loss tool.

Published literature
0human trials0human studies2animal1in vitro

No controlled human trial tests the injectable Lipo-B/MIC B-12 combination for weight loss; evidence is component-level nutrition literature and lipotropic-deficiency models, not product-specific RCT evidence.

Evidence reality check
Human evidence
No human studies
0 observational; RCT evidence not present in corpus.
Preclinical base
3 lab signals
2 animal; 1 in-vitro/mechanistic.
Risk posture
No major flags listed
Review route-specific cautions before use.
Properties
Injectable: extrapolated
Evidence
CAnimal replicated
Standard Formulations
Typical Lipo-B concentrations (vary by pharmacy): Methionine: 25-50 mg/mL; Inositol: 50-100 mg/mL; Choline chloride: 50-100 mg/mL; B12 (cyanocobalamin or methylcobalamin): 500-1000 mcg/mL. Extended formulations may add: Thiamine (B1), Pyridoxine (B6), Dexpanthenol (B5), Riboflavin (B2). Lipo-C (next chapter) adds L-Carnitine to the Lipo-B base. Standard administration: 1 mL intramuscular injection, 1-2x per week. Some protocols allow SubQ; IM is standard.
The Evidence Situation — Honest Summary
The Lipo-B combination has no randomized controlled trial evidence as a weight loss intervention. Zero. The evidence base is entirely at the component level — each ingredient has individual research relevant to specific physiological roles. Inositol has the strongest individual evidence (Grade B for PCOS/insulin resistance via oral supplementation). Choline and methionine have nutritional deficiency prevention evidence. B12 injection has established evidence for deficiency treatment. None of these individually, or combined, have been tested against placebo as an injectable lipotropic weight loss treatment in a controlled trial.
Why People Use It
Medspa and weight loss clinic use: offered as an adjunct to diet programs, GLP-1 medications, or lifestyle modification; typically 1-2x/week injections; often combined with semaglutide/tirzepatide protocols. The rationale offered to patients: enhanced fat metabolism; liver detoxification support; energy boost from B12; insulin sensitivity support from inositol; methyl donor support for methylation pathways. The clinical reality: most of these effects are nutrient-sufficiency level, not pharmacological; the injection provides no meaningful bioavailability advantage over oral for methionine, inositol, or choline; the B12 injection is the only component with a genuine parenteral advantage (for deficiency).
Lipo-B vs Lipo-C
Lipo-B (MIC B-12): Methionine + Inositol + Choline + B12. Lipo-C (next chapter): Methionine + Inositol + Choline + L-Carnitine + B vitamins (usually B1, B5) + B12. Lipo-C = Lipo-B plus L-Carnitine. The L-Carnitine addition in Lipo-C adds the mitochondrial fatty acid transport mechanism covered in the L-Carnitine chapter. The clinical significance of the L-Carnitine addition in an injectable form is the same as the L-Carnitine chapter's analysis — beneficial for deficient populations, modest for carnitine-replete individuals.
Simple view

Need the deep dive?

The default page keeps the decision layer visible first: summary, routes, evidence, and risks. Open the full report for mechanisms, chapter sections, citations, updates, and print/share controls.

Check interactions